Juergen Koester - Concepedia

Concepedia

Author

Juergen Koester

Boehringer Ingelheim (Germany)

Also Known As

J Koester, J. Koester, Juergen Koester

27

Publications

2.4K

Citations

11

H-Index

19

Concepts

All Affiliations

Boehringer Ingelheim (Germany)University of Helsinki Finnish Institute of Occupational Health Boehringer Ingelheim (Finland)Philipps University of Marburg

JK

About

Juergen Koester is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacotherapy, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	409
2	Pharmacology	2	2	183
3	Social Sciences	1	1	137
4	Kinesiology	1	1	42
5	Neuroscience	1	1	137

Juergen Koester

×

11

Publications

2.4K

Citations

11

H-Index

	Year	Citations
Impulse Control Disorders in Parkinson Disease Daniel Weintraub, Juergen Koester, Marc N. Potenza, Archives of Neurology	2010	1.4K
Efficacy and safety of pramipexole in restless legs syndrome John W. Winkelman, Kapil D. Sethi, Clete A. Kushida, Neurology	2006	194
Anhedonia, Depression, and Motor Functioning in Parkinson’s Disease During Treatment With Pramipexole Matthias Lemke, H. M. Brecht, Juergen Koester, Journal of Neuropsychiatry	2005	157
Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE study Markku Partinen, Kari Hirvonen, Leni Jama, Sleep Medicine MedicinePharmacotherapyPharmacologyAnesthesiology	2006	148
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease Matthias Lemke, H. M. Brecht, Juergen Koester, Journal of the Neurological Sciences NeuropsychologyPsychoactive DrugPsychiatryPsychotropic MedicationMotor Functioning	2006	137
Efficacy of pramipexole in restless legs syndrome: A six‐week, multicenter, randomized, double‐blind study (effect‐RLS study) Wolfgang H. Oertel, Karin Stiasny‐Kolster, Bettina Bergtholdt, Movement Disorders	2006	130
Controlled withdrawal of pramipexole after 6 months of open‐label treatment in patients with restless legs syndrome Claudia Trenkwalder, Karin Stiasny‐Kolster, Andreas Kupsch, Movement Disorders	2006	84
Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood Pasquale Montagna, Magdolna Hornyak, Jan Ulfberg, Sleep Medicine PsychiatryPsychotropic MedicationNeuropharmacologyPharmacotherapyMood Disorders	2010	47
A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: Polysomnographic evaluation of periodic leg movements and sleep disturbance Leni Jama, Kari Hirvonen, Markku Partinen, Sleep Medicine SleepKinesiologyRestless Legs SyndromeSleep DisturbanceDose-ranging Study	2009	42
Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study) Markku Partinen, Kari Hirvonen, Leni Jama, Sleep Medicine PharmacologyPrelude StudyPharmacotherapyOpen-label StudyMedicine	2008	35

Page 1